Population-based experience on primary central nervous system lymphoma 2000–2012: the incidence is increasing-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Population-based experience on primary central nervous system lymphoma 2000–2012: the incidence is increasing

Published:2017-01-13 Issue:4 Volume:56 Page:599-607
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Enblad Gunilla¹,Martinsson Gustaf¹,Baecklund Eva²,Hesselager Göran³,Sundström Christer⁴,Amini Rosie-Marie⁴,Hagberg Hans¹

Affiliation:

1. Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology, Uppsala University, Sweden;

2. Department of Medical Sciences, Uppsala University, Sweden;

3. Department of Neurosciences, Uppsala University, Sweden;

4. Department of Immunology, Genetics and Pathology, Uppsala University, Sweden

Funder

Swedish Cancer Foundation and the Lions research foundation

Lions Cancer foundation Uppsala

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2016.1270465

Reference26 articles.

1. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications

2. The changing incidence of primary central nervous system lymphoma is driven primarily by the changing incidence in young and middle‐aged men and differs from time trends in systemic diffuse large B‐cell non‐Hodgkin's lymphoma

3. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma

4. Trends in primary central nervous system lymphoma incidence and survival in the U.S.

5. Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System;Infection and Drug Resistance;2023-07

2. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives;Japanese Journal of Ophthalmology;2023-05-20

3. A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis;Frontiers in Oncology;2023-03-28

4. Pretreatment findings on magnetic resonance imaging in primary central nervous system lymphoma may predict overall survival duration;The Neuroradiology Journal;2023-01-30

5. Orelabrutinib-bruton tyrosine kinase inhibitor-based regimens in the treatment of central nervous system lymphoma: a retrospective study;Investigational New Drugs;2022-02-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3